<DOC>
	<DOC>NCT01686581</DOC>
	<brief_summary>This is an observational study to describe the long term use of Onabotulinumtoxin A (BOTOX®) as prescribed by the physician for headache prophylaxis in adults with chronic migraine. All treatment decisions lie with the physician.</brief_summary>
	<brief_title>An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Prescribed BOTOX® for the prophylaxis of headaches Received treatment with any botulinum toxin Type A serotype in the last 26 weeks Current participation in Allergan's Botox Chronic Migraine PostAuthorisation Safety Study (protocol 191622110)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>